Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17669014 | 0.94 | — | — | |
| SCHEMBL17668996 | 0.86 | — | — | |
| SCHEMBL17668941 | 0.83 | — | — | |
| SCHEMBL17669019 | 0.83 | — | — | |
| SCHEMBL17953129 | 0.81 | — | — | |
| SCHEMBL17668946 | 0.80 | LMNA (0.31) | — | |
| SCHEMBL22009319 | 0.78 | ALDH1A1 (0.31) | ALDH1A1TSHR | |
| SCHEMBL22008370 | 0.78 | ALDH1A1 (0.31) | ALDH1A1TSHR | |
| SCHEMBL319741 | 0.77 | MAPK1 (0.31) | — | |
| SCHEMBL27935858 | 0.77 | TSHR (0.39) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3009439-B1 | CYCLIC AMINOORGANOXYSILANE COMPOUND AND ITS PRODUCTION METHOD | SHINETSU CHEMICAL CO (JP) | 2018-01-03 | — | — | EP | disclosed |
| US-9371341-B2 | Cyclic aminoorganoxysilane compound and its production method | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-06-21 | — | — | US | disclosed |
| EP-3009439-A1 | CYCLIC AMINOORGANOXYSILANE COMPOUND AND ITS PRODUCTION METHOD | Shin-Etsu Chemical Co., Ltd. (JP) | 2016-04-20 | — | — | EP | disclosed |
| US-20160102111-A1 | CYCLIC AMINOORGANOXYSILANE COMPOUND AND ITS PRODUCTION METHOD | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160102111-A1 | CYCLIC AMINOORGANOXYSILANE COMPOUND AND ITS PRODUCTION METHOD | BCAT2, BCAT1, AKR1B10 | ALDH1A1 517/4885TSHR 1125/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.